DelveInsight’s “Opioid Induced Constipation Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in- depth understanding of the Opioid Induced Constipation , historical and forecasted epidemiology as well as the Opioid Induced Constipation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Opioid Induced Constipation is a specific type of constipation caused by Opioids – a type of prescription pain medication. Opioids block pain signals by attaching to receptors found throughout the nervous system. However, when opioids bind to receptors in the gut, the amount of time required by the stools to pass through the gastrointestinal system is prolonged, thus inducing constipation.
Some facts about Opioid Induced Constipation Market:
- According to results from a 2012 National Health and Wellness Survey, 50% of patients with Opioid Induced Constipation modified their opioid therapy because of constipation, while 20% discontinued the treatment.
- Based on BFI scores, physician assessments, and SBM frequency, the cumulative incidences of Opioid Induced Constipation in Japanese patients was between 45% to 61%.
Request for Free Sample Report:
https://www.delveinsight.com/sample-request/opioid-induced-constipation-market
Scope of the Opioid Induced Constipation Market Report:
- The report covers the descriptive overview of Opioid Induced Constipation , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Opioid Induced Constipation epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Opioid Induced Constipation are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Opioid Induced Constipation market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Opioid Induced Constipation market
Opioid Induced Constipation Symptoms & Causes:
Common physical symptoms of opioid-induced constipation include dry or hard stools, bloating or distention or bulging in the abdomen, nausea, vomiting, appetite loss, straining or forcing and feeling pain while defecating, etc.
The central nervous system controls the pain response along with other involuntary body movements that make digestion possible. Since opioids have the effect of slowing down the central nervous system, they can result in constipation.
Request for Free Sample Report:
https://www.delveinsight.com/sample-request/opioid-induced-constipation-market
Some of Opioid Induced Constipation Companies:
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Shionogi Inc.
- HealthCore, Inc.
- Ironwood Pharmaceuticals, Inc.
- And many others
Opioid Induced Constipation Therapies Covered:
- Methylnaltrexone (MNTX)
- Naldemedine
- Lubiprostone
- Linaclotide 290 micrograms
- And Many Others
Table of Contents:
- Key Insights
- Executive Summary of Opioid Induced Constipation
- Competitive Intelligence Analysis for Opioid Induced Constipation
- Opioid Induced Constipation : Market Overview at a Glance
- Opioid Induced Constipation : Disease Background and Overview
- Patient Journey
- Opioid Induced Constipation Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Opioid Induced Constipation Treatment
- Marketed Products
- Emerging Therapies
- Opioid Induced Constipation : Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of Opioid Induced Constipation
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Related Reports:
DelveInsight’s “Partial Seizure Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Partial Seizure, historical and forecasted epidemiology as well as the Partial Seizure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/opioid-induced-constipation-market